| |
| |
|
| Insider
Information: |
Chavez R Martin Phd |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
149,999 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$35,780,904 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
149,999 |
|
|
| Total
Value |
$35,780,904 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PNM Resources Inc |
PNM |
Director |
2004-03-10 |
1,427 |
2004-03-10 |
0 |
Premium* |
|
|
Goldman Sachs Group Inc |
GS |
|
2018-02-07 |
76,829 |
2018-02-07 |
0 |
Premium* |
|
|
Recursion Pharmaceuticals, Inc. |
RXRX |
Director |
2024-04-01 |
60,078 |
2021-04-16 |
0 |
Premium* |
|
|
Alphabet Inc |
GOOG |
Director |
2023-07-05 |
11,665 |
2022-08-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2024-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,001 |
60,078 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,900 |
58,077 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2023-10-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,619 |
56,177 |
0 |
- |
|
| GOOG |
Alphabet Inc |
Director |
– • – |
2023-07-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,841 |
2,841 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2023-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,541 |
53,558 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2023-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
12,612 |
51,017 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2023-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,721 |
38,405 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,483 |
35,684 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2022-10-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,725 |
33,201 |
0 |
- |
|
| GOOG |
Alphabet Inc |
Director |
– • – |
2022-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
8,824 |
8,824 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2022-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,224 |
31,476 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2022-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
18,145 |
29,252 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2022-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,438 |
11,107 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,040 |
8,669 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2021-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
858 |
7,629 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2021-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
521 |
6,771 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2021-04-20 |
4 |
A |
$0.00 |
$0 |
D/D |
6,250 |
6,250 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2021-04-20 |
4 |
A |
$0.00 |
$0 |
D/D |
6,250 |
0 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2021-04-16 |
4 |
A |
$0.00 |
$0 |
D/D |
6,250 |
6,250 |
0 |
- |
|
| GS |
Goldman Sachs Group Inc |
Executive Vice President - CFO |
• – – |
2018-02-07 |
4 |
AS |
$257.46 |
$2,667,534 |
D/D |
(10,289) |
76,829 |
0 |
- |
|
| GS |
Goldman Sachs Group Inc |
Executive Vice President - CFO |
• – – |
2018-02-07 |
4 |
AS |
$257.39 |
$398,837 |
I/I |
(1,540) |
0 |
0 |
- |
|
| GS |
Goldman Sachs Group Inc |
Executive Vice President - CFO |
• – – |
2018-02-07 |
4 |
AS |
$257.46 |
$2,667,534 |
D/D |
(10,289) |
76,829 |
0 |
- |
|
| GS |
Goldman Sachs Group Inc |
Executive Vice President - CFO |
• – – |
2018-02-07 |
4 |
AS |
$257.39 |
$398,837 |
I/I |
(1,540) |
0 |
0 |
- |
|
| GS |
Goldman Sachs Group Inc |
Executive Vice President - CFO |
• – – |
2018-01-31 |
4 |
AS |
$266.96 |
$413,978 |
I/I |
(1,540) |
1,540 |
0 |
- |
|
| GS |
Goldman Sachs Group Inc |
Executive Vice President - CFO |
• – – |
2018-01-31 |
4 |
AS |
$267.01 |
$2,764,848 |
D/D |
(10,289) |
87,118 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
